Literature DB >> 27048402

Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer.

Suguru Yamada1, Tsutomu Fujii2, Akihiro Hirakawa3, Mitsuro Kanda2, Hiroyuki Sugimoto2, Yasuhiro Kodera2.   

Abstract

PURPOSE: To determine which indicators, anatomical nodal metastasis (Japan Pancreas Society, JPS), number of positive lymph nodes (PLN), or lymph node ratio (LNR), is the best means of assessing lymph node involvement in pancreatic cancer.
METHODS: This retrospective study analyzed 275 patients with pancreatic cancer treated at a single institution. Survival curves according to the JPS, PLN, or LNR were assessed by the Kaplan-Meier method. Prognostic value of each classification was explored by Cox regression analysis after adjustments for clinical factors.
RESULTS: Multivariate analysis showed that, relative to n0 in the JPS, hazard ratios (HR) in n1, n2, and n3 were 1.72, 1.73, and 2.75, respectively, with no difference in survival between n1 and n2. Relative to PLN of 0, the HR in the PLN categories of 1∼2, 3, and >3 were 1.39, 1.65, and 3.03, respectively. Relative to LNR of 0, the HR in the categories of 0 < LNR ≤ 0.1, 0.1 < LNR ≤ 0.2, and LNR > 0.2 were 1.27, 2.00, and 5.58, respectively. An incremental increase in the HR was observed as the LNR category progressed, and differences between the survivals were distinct when stratified by the LNR.
CONCLUSIONS: The LNR was an accurate predictor of survival among three assessment strategies and could be proposed as a candidate for use as N categories, pending validation studies.

Entities:  

Keywords:  Lymph node metastasis; Lymph node ratio; Pancreatic cancer; Prognosis

Mesh:

Year:  2016        PMID: 27048402     DOI: 10.1007/s00423-016-1412-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  37 in total

1.  Number versus distribution in classifying regional lymph node metastases from colon cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Masayuki Yasutomi; Takehito Yoshifuji; Tomohiko Matsuzaki; Toshihiro Uchida; Eizaburou Ishimaru; Tadao Tokoro; Hitoshi Shiozaki
Journal:  J Am Coll Surg       Date:  2005-08       Impact factor: 6.113

2.  Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.

Authors:  Suzanne C Schiffman; Kelly M McMasters; Charles R Scoggins; Robert C Martin; Anees B Chagpar
Journal:  J Am Coll Surg       Date:  2011-05-20       Impact factor: 6.113

3.  Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein.

Authors:  A Nakao; H Takagi
Journal:  Hepatogastroenterology       Date:  1993-10

4.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

5.  Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.

Authors:  Giuseppe Malleo; Laura Maggino; Paola Capelli; Francesco Gulino; Silvia Segattini; Aldo Scarpa; Claudio Bassi; Giovanni Butturini; Roberto Salvia
Journal:  J Am Coll Surg       Date:  2015-02-28       Impact factor: 6.113

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

7.  Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.

Authors:  George Z Cheng; Wei Zhou Zhang; Mei Sun; Qi Wang; Domenico Coppola; Mena Mansour; Li Mei Xu; Carliann Costanzo; Jin Q Cheng; Lu-Hai Wang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

8.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

9.  Lymph node metastases in carcinoma of the head of the pancreas region.

Authors:  A Nakao; A Harada; T Nonami; T Kaneko; H Murakami; S Inoue; Y Takeuchi; H Takagi
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  13 in total

1.  Clinical impact of additional therapy for residual pancreatic cancer.

Authors:  Suguru Yamada; Fuminori Sonohara; Mitsuru Tashiro; Kenta Murotani; Hideki Takami; Masamichi Hayashi; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Goro Nakayama; Masahiko Koike; Tsutomu Fujii; Yasuhiro Kodera
Journal:  Surg Today       Date:  2019-10-24       Impact factor: 2.549

2.  Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies.

Authors:  Gianluca Tomasello; Michele Ghidini; Antonio Costanzo; Antonio Ghidini; Alessandro Russo; Sandro Barni; Rodolfo Passalacqua; Fausto Petrelli
Journal:  J Gastrointest Oncol       Date:  2019-04

3.  Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement.

Authors:  Giovanni Ramacciato; Giuseppe Nigri; Niccolo' Petrucciani; Antonio Daniele Pinna; Matteo Ravaioli; Elio Jovine; Francesco Minni; Gian Luca Grazi; Piero Chirletti; Giuseppe Tisone; Fabio Ferla; Niccolo' Napoli; Ugo Boggi
Journal:  BMC Surg       Date:  2017-11-23       Impact factor: 2.102

4.  One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review.

Authors:  Philip Anthony Sutera; Mark E Bernard; Beant S Gill; Kamran K Harper; Kimmen Quan; Nathan Bahary; Steven A Burton; Herbert Zeh; Dwight E Heron
Journal:  Front Oncol       Date:  2017-11-14       Impact factor: 6.244

5.  Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.

Authors:  Philip Sutera; Mark E Bernard; Hong Wang; Nathan Bahary; Steven Burton; Herbert Zeh; Dwight E Heron
Journal:  Front Oncol       Date:  2018-03-07       Impact factor: 6.244

6.  Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment.

Authors:  Chaobin He; Shuxin Sun; Yu Zhang; Xiaojun Lin; Shengping Li
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

7.  Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins.

Authors:  Mark E Bernard; Philip A Sutera; Nicholas A Iarrobino; Kimmen Quan; Steven A Burton; Nathan Bahary; Melissa Hogg; Amer Zureikat; Dwight E Heron
Journal:  Adv Radiat Oncol       Date:  2018-11-29

8.  Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma.

Authors:  Philip A Sutera; Mark E Bernard; Hong Wang; Dwight E Heron
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

9.  Multivisceral resection for adenocarcinoma of the pancreatic body and tail-a retrospective single-center analysis.

Authors:  Oliver Beetz; Akin Sarisin; Alexander Kaltenborn; Jürgen Klempnauer; Michael Winkler; Gerrit Grannas
Journal:  World J Surg Oncol       Date:  2020-08-20       Impact factor: 2.754

10.  Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.

Authors:  Huan-Jun Li; Yu-Tong Chen; Shu-Qiang Yuan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.